Explore Jobs
Find Specific Jobs
Explore Careers
Explore Professions
Best Companies
Explore Companies
ResMed revenue
ResMed's revenue is $4.7 billion.
What is ResMed's revenue?
- ResMed's revenue growth from 2003 to 2024 is 1,612.65%.
- ResMed has 8,000 employees, and the revenue per employee ratio is $585,662.
- ResMed's peak quarterly revenue was $1.3B in 2025(q2).
- ResMed peak revenue was $4.7B in 2024.
- ResMed annual revenue for 2023 was 4.2B, 18.02% growth from 2022.
- ResMed annual revenue for 2024 was 4.7B, 10.95% growth from 2023.
On This Page
We apply to jobs. You watch Netflix. Only $10.
ResMed historical revenue
ResMed's peak revenue was $4.7B in 2024. The peak quarterly revenue was $1.3B in 2025(q2).
ResMed's revenue increased from $273.6m in 2003 to $4.7B currently. That's a 1,612.65% change in annual revenue.
ResMed annual revenue
ResMed annual revenue over time
| Fiscal Year / Year | ResMed Revenue |
|---|---|
| 2009 | $920.7M |
| 2010 | $1.1B |
| 2011 | $1.2B |
| 2012 | $1.4B |
| 2013 | $1.5B |
| 2014 | $1.6B |
| 2015 | $1.7B |
| 2016 | $1.8B |
| 2017 | $2.1B |
| 2018 | $2.3B |
| 2019 | $2.6B |
| 2020 | $3.0B |
| 2021 | $3.2B |
| 2022 | $3.6B |
| 2023 | $4.2B |
| 2024 | $4.7B |
Rate ResMed's financial transparency
ResMed annual growth
ResMed saw the greatest revenue growth in 2006, when revenue increased by 42.65%.
ResMed had the lowest revenue growth in 2014, when revenue changed by 2.68%.
ResMed annual growth rate over time
| Year | ResMed Growth |
|---|---|
| 2009 | 10%↑ |
| 2010 | 19%↑ |
| 2011 | 14%↑ |
| 2012 | 10%↑ |
| 2013 | 11%↑ |
| 2014 | 3%↑ |
| 2015 | 8%↑ |
| 2016 | 10%↑ |
| 2017 | 12%↑ |
| 2018 | 13%↑ |
| 2019 | 11%↑ |
| 2020 | 13%↑ |
| 2021 | 8%↑ |
| 2022 | 12%↑ |
| 2023 | 18%↑ |
| 2024 | 11%↑ |
ResMed quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
ResMed quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $217.9M | $223.0M | $227.9M | $252.0M |
| 2010 | $247.0M | $275.1M | $278.7M | $291.6M |
| 2011 | $282.0M | $306.0M | $313.3M | $341.9M |
| 2012 | $314.8M | $332.7M | $349.1M | $371.9M |
| 2013 | $339.7M | $376.5M | $383.6M | $414.6M |
| 2014 | $357.7M | $384.3M | $397.8M | $415.2M |
| 2015 | $380.4M | $423.0M | $422.5M | $453.1M |
| 2016 | $411.6M | $454.5M | $453.9M | $518.6M |
| 2017 | $465.5M | $530.4M | $514.2M | $556.7M |
| 2018 | $523.7M | $601.3M | $591.6M | $623.6M |
| 2019 | $588.3M | $651.1M | $662.2M | $705.0M |
| 2020 | $681.1M | $736.2M | $769.5M | $770.3M |
| 2021 | $751.9M | $800.0M | $768.8M | $876.1M |
| 2022 | $904.0M | $894.9M | $864.5M | $914.7M |
| 2023 | $950.3M | $1.0B | $1.1B | $1.1B |
| 2024 | $1.1B | $1.2B | $1.2B | $1.2B |
| 2025 | $1.2B | $1.3B | - | - |
ResMed Jobs Nearby
Do you work at ResMed?
Is ResMed transparent about its revenue structure?
ResMed Financial Information
| CEO | Michael “Mick” Farrell |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 8,000 |
| Date Founded | 1989 |
| Headquarters | San Diego, California |
| Number of Locations | 4 |
| Revenue | $4.7B |
| Net Income | $897,556,000 |
| Gross Proft | $2.7B (2024) |
| EBITDA | $1.4B (2024) |
| PE Ratio | 13.07 |
| Tax Rate | 0.2% |
| Market Capitalization | $13.3B |
| Total Assets | $6,751,708,000 |
| Ticker | RMD |
ResMed Jobs You Might Like
ResMed Financing
ResMed received early financing of $500.0M on 2019-07-15.
| Series | Round Size | Date |
|---|---|---|
| Post Ipo Debt | $500M | 07/2019 |
ResMed competitors
ResMed's top competitor, McKesson, earned an annual revenue of $309.0B.
ResMed's smallest competitor is Achieve Services with revenue of $480.0K last year.
| Company Name | Average Salary | Revenue | Employee Size | Job Openings |
|---|---|---|---|---|
| NuVasive | $75,654 | $1.2B | 2,800 | 7 |
| Stryker | $69,470 | $22.6B | 43,000 | 1,696 |
| Abiomed | $99,022 | $1.0B | 1,536 | - |
| Boston Scientific | $60,291 | $16.7B | 36,000 | 537 |
| Sanofi Genzyme | $84,495 | $4.6B | 12,000 | 41 |
| McKesson | $51,976 | $309.0B | 80,000 | 361 |
| Intersect ENT | $67,446 | $106.7M | 393 | - |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 451 |
| Merck | $90,328 | $64.2B | 74,000 | 1,005 |
| Ardent Technologies | $73,368 | $1.6M | 30 | - |
Search for jobs
Related Company Revenues
Working At Related Companies
Related Company Jobs
ResMed Highest Paying Jobs
Zippia gives an in-depth look into the details of ResMed, including salaries, political affiliations, employee data, and more, in order to inform job seekers about ResMed. The employee data is based on information from people who have self-reported their past or current employments at ResMed. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by ResMed. The data presented on this page does not represent the view of ResMed and its employees or that of Zippia.
ResMed may also be known as or be related to ResMed, ResMed Inc, ResMed Inc., ResMed, Inc. and Resmed Inc.